These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 26300071)

  • 21. Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
    Reu FJ; Bae SI; Cherkassky L; Leaman DW; Lindner D; Beaulieu N; MacLeod AR; Borden EC
    J Clin Oncol; 2006 Aug; 24(23):3771-9. PubMed ID: 16801630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interferon alpha2b differentially affects proliferation of two human renal cell carcinoma cell lines differing in the P-glycoprotein-associated multidrug-resistant phenotype.
    Frank MH; Pomer S
    J Cancer Res Clin Oncol; 1999; 125(2):117-20. PubMed ID: 10190320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fraction From Lycium barbarum Polysaccharides Reduces Immunotoxicity and Enhances Antitumor Activity of Doxorubicin in Mice.
    Deng X; Luo S; Luo X; Hu M; Ma F; Wang Y; Zhou L; Huang R
    Integr Cancer Ther; 2018 Sep; 17(3):860-866. PubMed ID: 29355051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic effects of Lycium barbarum polysaccharide (LBP) on mitomycin C (MMC)-induced myelosuppressive mice.
    Hai-Yang G; Ping S; Li JI; Chang-Hong X; Fu T
    J Exp Ther Oncol; 2004 Oct; 4(3):181-7. PubMed ID: 15724837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humanised antihuman IL-6R antibody with interferon inhibits renal cell carcinoma cell growth in vitro and in vivo through suppressed SOCS3 expression.
    Oguro T; Ishibashi K; Sugino T; Hashimoto K; Tomita S; Takahashi N; Yanagida T; Haga N; Aikawa K; Suzutani T; Yamaguchi O; Kojima Y
    Eur J Cancer; 2013 May; 49(7):1715-24. PubMed ID: 23274199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.
    Kurabayashi A; Inoue K; Fukuhara H; Karashima T; Fukata S; Kawada C; Shuin T; Furihata M
    Cancer Sci; 2015 Aug; 106(8):1092-9. PubMed ID: 26041278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the antitumor activities of IFN-alpha8 on renal cell carcinoma cells in vitro.
    Yanai Y; Horie S; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M; Kitamura T
    J Interferon Cytokine Res; 2001 Dec; 21(12):1129-36. PubMed ID: 11798471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
    Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
    Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of Fas-mediated apoptosis in renal cell carcinoma cells by adriamycin.
    Wu XX; Mizutani Y; Kakehi Y; Yoshida O; Ogawa O
    Cancer Res; 2000 Jun; 60(11):2912-8. PubMed ID: 10850437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arabinogalactan derived from Lycium barbarum fruit inhibits cancer cell growth via cell cycle arrest and apoptosis.
    Gong G; Liu Q; Deng Y; Dang T; Dai W; Liu T; Liu Y; Sun J; Wang L; Liu Y; Sun T; Song S; Wang Z; Huang L
    Int J Biol Macromol; 2020 Apr; 149():639-650. PubMed ID: 31991207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
    Trott JF; Kim J; Abu Aboud O; Wettersten H; Stewart B; Berryhill G; Uzal F; Hovey RC; Chen CH; Anderson K; Graef A; Sarver AL; Modiano JF; Weiss RH
    Oncotarget; 2016 Oct; 7(41):66540-66557. PubMed ID: 27572319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of macrophages by polysaccharide-protein complex from Lycium barbarum L.
    Chen Z; Soo MY; Srinivasan N; Tan BK; Chan SH
    Phytother Res; 2009 Aug; 23(8):1116-22. PubMed ID: 19170138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The novel histone deacetylase inhibitor, N-hydroxy-7-(2-naphthylthio) hepatonomide, exhibits potent antitumor activity due to cytochrome-c-release-mediated apoptosis in renal cell carcinoma cells.
    Park KC; Heo JH; Jeon JY; Choi HJ; Jo AR; Kim SW; Kwon HJ; Hong SJ; Han KS
    BMC Cancer; 2015 Jan; 15():19. PubMed ID: 25613585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potent antitumor activity of a novel nucleoside analogue, BCH-4556 (beta-L-dioxolane-cytidine), in human renal cell carcinoma xenograft tumor models.
    Kadhim SA; Bowlin TL; Waud WR; Angers EG; Bibeau L; DeMuys JM; Bednarski K; Cimpoia A; Attardo G
    Cancer Res; 1997 Nov; 57(21):4803-10. PubMed ID: 9354442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth inhibition and cell-cycle arrest of human gastric cancer cells by Lycium barbarum polysaccharide.
    Miao Y; Xiao B; Jiang Z; Guo Y; Mao F; Zhao J; Huang X; Guo J
    Med Oncol; 2010 Sep; 27(3):785-90. PubMed ID: 19669955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effects of oral administration of an interferon-inducing pyrimidinone, Bropirimine, on murine renal-cell carcinoma.
    Fujioka T; Ishikura K; Hasegawa M; Ogyu K; Matsushita Y; Sato M; Sato F; Aoki H; Kubo T
    Cancer Chemother Pharmacol; 1995; 36(1):7-12. PubMed ID: 7536641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor and antiangiogenic activity of Schisandra chinensis polysaccharide in a renal cell carcinoma model.
    Qu HM; Liu SJ; Zhang CY
    Int J Biol Macromol; 2014 May; 66():52-6. PubMed ID: 24556120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antitumor efficacy of recombinant human interleukin-2 combined with sorafenib against mouse renal cell carcinoma.
    Iguchi M; Matsumoto M; Hojo K; Wada T; Matsuo Y; Arimura A; Abe K
    Jpn J Clin Oncol; 2009 May; 39(5):303-9. PubMed ID: 19336449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical modulation of 5-fluorouracil with murine interferon-alpha/beta against murine renal cell carcinoma.
    Marumo K; Oya M; Murai M
    Int J Urol; 1997 Mar; 4(2):163-8. PubMed ID: 9179690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel SN-38-incorporated polymeric micelle, NK012, strongly suppresses renal cancer progression.
    Sumitomo M; Koizumi F; Asano T; Horiguchi A; Ito K; Asano T; Kakizoe T; Hayakawa M; Matsumura Y
    Cancer Res; 2008 Mar; 68(6):1631-5. PubMed ID: 18339841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.